Abstract
The results of phytochemical investigation, over the last decade, of some wild-growing plant species from Serbia and Montenegro belonging to the families Asteraceae, Guttiferae and Gentianaceae are reported. Most of the investigated species are endemites and the emphasis in this report is on those exhibiting biological activities that could be regarded as the potential sources of drugs. This review comprises 154 compounds, e.g. sesquiterpene lactones and flavonoids (Asteraceae), xanthones, secoiridoids and C-glucoflavonoids (Gentanaceae) and prenylated phloroglucinols (Guttiferae) as well as some other secondary metabolites, produced by the above families, which could be of pharmacological interest.
Keywords: Asteraceae, Guttiferae, Gentianaceae, sesquiterpene lactones, flavonoids, prenylated phloroglucinols, xanthones, secoiridoids
Current Pharmaceutical Design
Title: Some Wild-Growing Plant Species from Serbia and Montenegro as the Potential Sources of Drugs
Volume: 14 Issue: 29
Author(s): I. S. Aljancic, V. E. Vajs, V. V. Tesevic and S. M. Milosavljevic
Affiliation:
Keywords: Asteraceae, Guttiferae, Gentianaceae, sesquiterpene lactones, flavonoids, prenylated phloroglucinols, xanthones, secoiridoids
Abstract: The results of phytochemical investigation, over the last decade, of some wild-growing plant species from Serbia and Montenegro belonging to the families Asteraceae, Guttiferae and Gentianaceae are reported. Most of the investigated species are endemites and the emphasis in this report is on those exhibiting biological activities that could be regarded as the potential sources of drugs. This review comprises 154 compounds, e.g. sesquiterpene lactones and flavonoids (Asteraceae), xanthones, secoiridoids and C-glucoflavonoids (Gentanaceae) and prenylated phloroglucinols (Guttiferae) as well as some other secondary metabolites, produced by the above families, which could be of pharmacological interest.
Export Options
About this article
Cite this article as:
Aljancic S. I., Vajs E. V., Tesevic V. V. and Milosavljevic M. S., Some Wild-Growing Plant Species from Serbia and Montenegro as the Potential Sources of Drugs, Current Pharmaceutical Design 2008; 14 (29) . https://dx.doi.org/10.2174/138161208786404236
DOI https://dx.doi.org/10.2174/138161208786404236 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of Connexins in Carcinogenesis: Review of Current Knowledge
Current Signal Transduction Therapy Quantization of Angiogenesis and Image Analysis
Current Angiogenesis (Discontinued) Stable Synthetic Bacteriochlorins: Potent Light-Activated Anti-Cancer Drugs
Current Organic Chemistry Differentiation-Inducing Therapy for Solid Tumors
Current Pharmaceutical Design Nanocellulose-based Delivery Systems and Cervical Cancer: Review of the Literature
Current Pharmaceutical Design Psychological Sequelae of Ovarian Cancer Screening and Genetic Testing for Ovarian Cancer Susceptibility
Current Women`s Health Reviews Cancer Chemoprevention by Targeting the Epigenome
Current Drug Targets Clinical Pharmacology of Serotonin Receptor Type 3 (5-HT3) Antagonists
Current Medicinal Chemistry - Central Nervous System Agents Glucose-6-phosphate Dehydrogenase: a Biomarker and Potential Therapeutic Target for Cancer
Anti-Cancer Agents in Medicinal Chemistry The Current Role of PET/CT in Radiotherapy Planning
Current Radiopharmaceuticals Targeting the PI3K/Akt/mTOR Axis by Apigenin for Cancer Prevention
Anti-Cancer Agents in Medicinal Chemistry Application of Quantum Dots in Drug Delivery
Nanoscience & Nanotechnology-Asia Electromagnetic Energy as a Bridge Between Atomic and Cellular Levels in the Genetics Approach to Cancer Treatment
Current Topics in Medicinal Chemistry Polypharmacology in Drug Discovery: A Review from Systems Pharmacology Perspective
Current Pharmaceutical Design Recent Advances in Structural Studies of the Carbonic Anhydrase Family: The Crystal Structure of Human CA IX and CA XIII
Current Pharmaceutical Design Pharmacogenetics of Irinotecan Disposition and Toxicity: A Review
Current Clinical Pharmacology Oncolytic Virus: Regulatory Aspects from Quality Control to Clinical Studies
Current Cancer Drug Targets Modulation of Photosensitization Processes for an Improved Targeted Photodynamic Therapy
Current Medicinal Chemistry New Cathepsin D Inhibitor Library Utilizing Hydroxyethyl Isosteres with Cyclic Tertiary Amines
Medicinal Chemistry A Pan-Cancer Review of <i>ALK</i> Mutations: Implications for Carcinogenesis and Therapy
Current Cancer Drug Targets